DE3065342D1 - Chromium acetylacetonate as a dietary supplement and pharmaceutical agent - Google Patents

Chromium acetylacetonate as a dietary supplement and pharmaceutical agent

Info

Publication number
DE3065342D1
DE3065342D1 DE8080200219T DE3065342T DE3065342D1 DE 3065342 D1 DE3065342 D1 DE 3065342D1 DE 8080200219 T DE8080200219 T DE 8080200219T DE 3065342 T DE3065342 T DE 3065342T DE 3065342 D1 DE3065342 D1 DE 3065342D1
Authority
DE
Germany
Prior art keywords
pharmaceutical agent
chromium
dietary supplement
chromium acetylacetonate
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080200219T
Other languages
English (en)
Inventor
Dennis Patrick Riley
Mark Morgan Anderson
John Truman Rotruck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of DE3065342D1 publication Critical patent/DE3065342D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/92—Ketonic chelates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seeds, Soups, And Other Foods (AREA)
DE8080200219T 1979-03-19 1980-03-07 Chromium acetylacetonate as a dietary supplement and pharmaceutical agent Expired DE3065342D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2138279A 1979-03-19 1979-03-19

Publications (1)

Publication Number Publication Date
DE3065342D1 true DE3065342D1 (en) 1983-11-24

Family

ID=21803870

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080200219T Expired DE3065342D1 (en) 1979-03-19 1980-03-07 Chromium acetylacetonate as a dietary supplement and pharmaceutical agent

Country Status (10)

Country Link
US (1) US4571391A (de)
EP (1) EP0016496B1 (de)
JP (1) JPS565414A (de)
AT (1) ATE5049T1 (de)
AU (1) AU536196B2 (de)
CA (1) CA1154672A (de)
DE (1) DE3065342D1 (de)
IE (1) IE49650B1 (de)
NZ (1) NZ193164A (de)
ZA (1) ZA801555B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6831881A (en) * 1980-03-31 1981-10-08 Procter & Gamble Company, The Chromium complexes as dietary supplements and pharmaceutical agents
JPS5991861A (ja) * 1982-11-17 1984-05-26 Bikou:Kk 栄養補助食品カルシウム粒
DE3334516A1 (de) * 1983-09-23 1985-04-11 Siemens AG, 1000 Berlin und 8000 München Koppelfeld mit verbindungswegeumkehr, insbesondere fuer fernsprechvermittlungsanlagen
EP0265772B1 (de) * 1986-10-27 1992-12-23 Abbott Laboratories Flüssige Nährwert-Tabelle für Glukose-Intoleranz
IL95220A0 (en) * 1989-07-28 1991-06-10 Thymax Corp Dithiochrome,an insulinbinding molecule,pharmaceutical compositions containing it and methods for extracting it
US5420108A (en) * 1992-09-14 1995-05-30 Shohet; Isaac H. Method of controlling diabetes mellitus
US5811463A (en) * 1993-10-06 1998-09-22 University Of British Columbia Compositions and method for relaxing smooth muscles
US5631284A (en) * 1993-10-06 1997-05-20 University Of British Columbia Compositions and methods for relaxing smooth muscles
WO2003090671A2 (en) * 2002-04-23 2003-11-06 Nutrition 21, Inc. Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
US7247328B2 (en) * 2002-05-31 2007-07-24 Zinpro Corporation Chromium (III) alpha amino acid complexes
US20060029642A1 (en) * 2004-08-03 2006-02-09 Dusan Miljkovic Methods and compositions for improved chromium complexes
US20060083824A1 (en) * 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
CA3021932C (en) * 2007-01-31 2020-12-15 Jds Therapeutics, Llc Use of chromium histidinate for treatment of cardiometabolic disorders
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US9585898B2 (en) 2008-02-11 2017-03-07 Kenneth O. Russell Method for the reduction of dangerous blood sugar levels
US8932372B2 (en) 2010-02-02 2015-01-13 Celanese International Corporation Integrated process for producing alcohols from a mixed acid feed
ES2927800T3 (es) 2011-03-01 2022-11-11 Nutrition 21 Llc Composición de insulina y cromo para el tratamiento y la prevención de diabetes, hipoglicemia y trastornos relacionados
CN109069532A (zh) 2016-02-11 2018-12-21 营养21有限责任公司 含铬组合物用于改善健康和健身

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134797A (en) * 1960-06-13 1964-05-26 Diamond Alkali Co Preparation of chromium complexes of beta-diketones
US3914410A (en) * 1972-06-13 1975-10-21 Bristol Myers Co Method for preparing sucrose composition containing chromium III salt
US3925433A (en) * 1973-09-10 1975-12-09 Zinpro Corp 1:1 And 2:1 chromium, alpha amino acid complex salts

Also Published As

Publication number Publication date
NZ193164A (en) 1984-12-14
JPS565414A (en) 1981-01-20
ATE5049T1 (de) 1983-11-15
IE49650B1 (en) 1985-11-13
EP0016496B1 (de) 1983-10-19
CA1154672A (en) 1983-10-04
IE800547L (en) 1980-09-19
US4571391A (en) 1986-02-18
AU536196B2 (en) 1984-04-19
ZA801555B (en) 1981-04-29
EP0016496A1 (de) 1980-10-01
AU5650280A (en) 1980-09-25

Similar Documents

Publication Publication Date Title
DE3065342D1 (en) Chromium acetylacetonate as a dietary supplement and pharmaceutical agent
IL72469A0 (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
FI875533A0 (fi) Insulinpreparat foer non-parenteral dosering.
PH31617A (en) Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds.
AU586286B2 (en) Pharmaceutical and dietary composition
CA2029865A1 (en) Continuous/bolus infusor
ES1014870U (es) Jeringa de seguridad monouso.
GB2276086A (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
EP0453127A3 (en) Treatment of cataract with 15-keto-prostaglandin compounds
ES2011120A6 (es) Forma de dosificacion para tratar las enfermedades cardiovasculares.
WO1996015784A3 (de) 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz
ATE260886T1 (de) Verwendung allosterischer hämoglobinmodifikatoren zur verringerung der sauerstoffaktivität im blut
IL62847A (en) Pharmaceutical composition for the treatment of juvenile diabetes mellitus comprising insulin and l-carnitine and/or an l-acylcarnitine
EP0019403A3 (en) Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
CA2113856A1 (en) Antidiabetic Agent
KR890004690A (ko) 당뇨병의 치료를 위한 베자피브레이드의 용도
GB2002516A (en) Device for preparation of liquid control solutions
JPS5244222A (en) Method of making insulin preparations for rectal application
EP0037144A3 (de) Chromkomplexe als Diätzulage und pharmazeutische Mittel
IE46171L (en) N-pyrrolidinylmethylbenzamide derivative.
PL267525A1 (en) Agent for agricultural use
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
USD236891S (en) Best available copy
FR2475898B1 (de)
ES279057U (es) Jeringuilla para inyecciones

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee